Some IVIG brands, like Gammagard, contain added sugar. This could cause your blood glucose to rise temporarily. But studies don’t show weight gain as a typical side effect of IVIG. Intravenous ...

DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare, today announced a recent feature in the National Home Infusion Association’s (NHIA) Infusion Journal. The case ...

The prescribed dosage for Hizentra (immune globulin subcutaneous [human]) may vary depending on an individual’s treatment plan. Other factors, including your specific diagnosis, body weight, and ...

Dedicated Devices for HYQVIA [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] Reduce the Number of Steps and Ancillary Supplies Compared to a Pooling Bag When Preparing the ...

AOM Infusion ("AOM"), a leading provider of specialty infusion and pharmacy services for chronic and complex conditions, has been selected by Kedrion Biopharma as a limited distribution network ...

NEW YORK (Reuters Health) - Intravenous immunoglobulin (IVIg) may offer some relief for patients with sensorimotor neuropathy or nonataxic sensory neuropathy associated with primary Sjögren's syndrome ...

DALLAS--(BUSINESS WIRE)--Advanced Infusion Care (AIC), a division of AIS Healthcare, today announced its participation in the Immunoglobulin National Society (IgNS) 12 th National Conference, which ...

With use of intravenous immune globulin (IVIg) for the treatment of adults with dermatomyositis, a significantly higher percentage of patients experienced at least minimal improvement in disease ...

This was a single-arm, interventional-, single-center, open-label prospective study. Patients with a history of probable MSA [15] were enrolled in the study (Table 1). All patients had some ...

Nine-year-old Jack Stackpoole, who was diagnosed with autism at age 3, developed a host of new symptoms — severe tics, an aversion to eating and picking at himself until he bled — after getting sick ...

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Takeda (TSE:4502/NYSE:TAK) today announced full results from the pivotal Phase 3 ADVANCE-CIDP 1 clinical trial investigating HYQVIA® [Immune Globulin ...

ARLINGTON, Texas, December 02, 2025--(BUSINESS WIRE)--AOM Infusion ("AOM"), a leading provider of specialty infusion and pharmacy services for chronic and complex conditions, has been selected by ...